HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Claudia Ranucci Durante Selected Research

111In-DTPA-trastuzumab

1/2021Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Claudia Ranucci Durante Research Topics

Disease

1Neoplasms (Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1111In-DTPA-trastuzumabIBA
01/2021
1Chelating AgentsIBA
01/2021
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021